Our animal and cellular results consistently disclosed that Hamaudol treatment significantly improved endothelial dysfunction under diabetic state by restoring NKAα1 protein expression and inhibiting ACSL4‐mediated ferroptosis. Here, ACSL4 is linked to endothelial dysfunction.